Berberine improves glucose metabolism in diabetic rats by inhibition of hepatic gluconeogenesis.
Berberine (BBR) is a compound originally identified in a Chinese herbal medicine Huanglian (Coptis chinensis French). It improves glucose metabolism in type 2 diabetic patients. The mechanisms involve in activation of adenosine monophosphate activated protein kinase (AMPK) and improvement of insulin...
Main Authors: | Xuan Xia, Jinhua Yan, Yunfeng Shen, Kuanxiao Tang, Jun Yin, Yanhua Zhang, Dongjie Yang, Hua Liang, Jianping Ye, Jianping Weng |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2011-02-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC3033390?pdf=render |
Similar Items
-
G protein-coupled receptor 151 regulates glucose metabolism and hepatic gluconeogenesis
by: Ewa Bielczyk-Maczynska, et al.
Published: (2022-12-01) -
Leupaxin promotes hepatic gluconeogenesis and glucose metabolism by coactivation with hepatic nuclear factor 4α
by: Xiaomin Luo, et al.
Published: (2025-01-01) -
Unraveling the Regulation of Hepatic Gluconeogenesis
by: Xueping Zhang, et al.
Published: (2019-01-01) -
PIMT regulates hepatic gluconeogenesis in mice
by: Bandish Kapadia, et al.
Published: (2023-03-01) -
Hepatic ketone body regulation of renal gluconeogenesis
by: Ryo Hatano, et al.
Published: (2024-06-01)